航海家治療公司
US ˙ NasdaqGS ˙ US92915B1061

簡介

本頁面提供了有關 Steven M Paul 已知的內部交易歷史的全面分析。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。盡管存在這些限制,學術研究表明,內部人士 - 整體而言 - 在自己公司中的投資表現往往優於市場。

平均交易盈利能力

「平均交易盈利能力」衡量了內部人士在過去三年中所有非計劃性的公開市場購買交易的平均回報率。計算過程包括檢查每筆交易,排除了作為10b5-1交易計劃的一部分的交易。然後,對每筆交易在3、6和12個月的表現進行平均,以生成該筆交易最終的表現指標。最終,將所有交易的表現指標進行平均,計算出內部人士的總體平均表現指標。列表僅包含在過去兩年中進行過至少三筆交易的內部人士。

如果內部人士的交易盈利能力顯示為"N/A",則可能是因為該內部人士在過去三年內沒有進行任何公開市場購買交易,或者他們進行的交易距離現在太近,無法計算出可靠的表現指標。

更新頻率:每日

查看收益最高的的內幕交易者列表。

報告內部持倉的公司

SEC文件顯示Steven M Paul已報告在以下公司擁有持倉或進行了交易:

證券 職位 最新報告的持倉
Director 863,031
Director 41,666
US:KRTX / Karuna Therapeutics, Inc. Director 0
US:SAGE / Sage Therapeutics, Inc. Director 78,539
US:ALNY / Alnylam Pharmaceuticals, Inc. Director 0
US:VYGR / Voyager Therapeutics, Inc. Director 15,000
US:SIAL / Sigma-Aldrich Corporation Director 0
如何解讀這些圖表

以下圖表顯示了在Steven M Paul進行的每筆公開市場非計劃交易後證券的股價表現。非計劃交易是指沒有作為10b5-1交易計劃的一部分而進行的交易。股價表現以累積百分比變化的方式繪製。例如,如果一筆內部人士交易是在2019年1月1日進行的,該圖表將顯示該證券的每日百分比變化直至當前日期。如果在此期間股價從10美元漲至15美元,則股價的累積百分比變化將為50%。從10美元漲至20美元的價格變化將為100%,而從10美元跌至5美元的價格變化將為-50%。

最終,我們將評估內部人士的交易與股價的超額回報(正向或負向)之間的相關性,以判斷內部人士是否在交易中利用內部信息獲利。如果內部人士有這樣的行為,我們預期看到(a)購買後的正回報,或者(b)賣出後的負回報。對於情況(a),購買圖表將顯示一系列向上傾斜的曲線,表示每次購買後都有正回報。對於情況(b),賣出圖表將顯示一系列向下傾斜的曲線,表示每次賣出後都有負回報。

然而,僅憑這一點還不足以得出結論。例如,如果公司的股價在多年內呈現非周期性上升,我們會預期所有購買後的圖表都呈現向上傾斜。同樣地,多年來呈現非周期性下降的股價會導致賣出後的圖表也呈現向下傾斜。這兩種情況的圖表都不能表示內部人士在進行內幕交易。

最有力的指標是在公司股價呈極度循環波動的情況下,「購買」圖表顯示正向信號,而「賣出」圖表顯示負向趨勢。這種情況強烈暗示內部人士可能根據內幕信息精確地計時進行交易,以獲得財務優勢。

VYGR / Voyager Therapeutics, Inc.內部人士買入 - 短期收益分析

在這一部分,我們分析了在 VYGR / Voyager Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況,結果僅為理論值

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2016-01-14 VYGR PAUL STEVEN M 10,000 14.0690 10,000 14.0690 140,690 207 16.2600 21,910 15.57

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VYGR / Voyager Therapeutics, Inc. Insider Trades
VYGR / Voyager Therapeutics, Inc.內部人士賣出 - 短期虧損分析

在這一部分,我們分析了在 VYGR / Voyager Therapeutics, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況,

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 證券代碼 內部人士 報告
股數
Reported
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
當前未知該內部人士及證券組合進行過任何未預先計劃的公開市場交易。

經調整價格 已按拆股調整。經調整股數 已按拆股調整。

VYGR / Voyager Therapeutics, Inc. Insider Trades
歷史內部人交易

該表格顯示了由 Steven M Paul 進行的所有內幕交易的完整列表,這些交易已向美國證券交易委員會(SEC)披露。

呈報日期 交易日期 表格 證券代碼 證券 代碼 10b5-1 股份 剩餘股份 %
變化
每股
股價
交易
金額
剩餘
金額
2026-05-04 2026-05-04 4 SPTX Seaport Therapeutics, Inc.
Common Stock
C - Conversion 67,031 863,031 8.42
2026-04-30 3 SPTX Seaport Therapeutics, Inc.
Common Stock
796,000
2025-09-15 2025-09-12 4 RAPP Rapport Therapeutics, Inc.
Common Stock
P - Purchase 13,382 41,666 47.31 24.97 334,165 1,040,450
2025-09-15 2025-09-12 4 RAPP Rapport Therapeutics, Inc.
Common Stock
P - Purchase 28,284 28,284 24.50 692,947 692,947
2024-06-06 3 RAPP Rapport Therapeutics, Inc.
Common Stock
477,642
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -35,877 0 -100.00 330.00 -11,839,410
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30,304 0 -100.00 330.00 -10,000,320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -30,304 0 -100.00 330.00 -10,000,320
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -33,882 0 -100.00 330.00 -11,181,060
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -10,000 0 -100.00 330.00 -3,300,000
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -8,550 0 -100.00 330.00 -2,821,500
2024-03-18 2024-03-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
D - Sale to Issuer -2,046 8,550 -19.31 330.00 -675,180 2,821,500
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 30,304
2024-03-04 2024-03-04 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 2,364 -92.76
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 32,668 1,281.90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 30,304 32,668 1,281.90
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 10,000 -75.19
2024-03-04 2024-03-01 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -30,304 10,000 -75.19
2024-03-04 2024-02-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
J - Other 47,378 70,608 203.95 315.18 14,932,598 22,254,229
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 4,008 42,114 10.52 99.72 399,678 4,199,608
2024-02-26 2024-02-23 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 27,510 38,106 259.63 7.27 199,998 277,031
2024-02-12 2024-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
F - Taxes -804 10,596 -7.05 317.14 -254,981 3,360,415
2023-02-13 2023-02-09 4 KRTX Karuna Therapeutics, Inc.
Common Stock
A - Award 11,400 11,400
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106,485 106,485
2023-02-13 2022-05-31 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106,485 0 -100.00
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift 106,485 106,485
2023-02-13 2022-05-27 4 KRTX Karuna Therapeutics, Inc.
Common Stock
G - Gift -106,485 0 -100.00
2022-11-30 2022-11-28 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 5 78,539 0.01 38.17 191 2,997,637
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -15,000 0 -100.00
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -175 1,000 -14.89 178.60 -31,255 178,600
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -825 1,175 -41.25 177.58 -146,504 208,656
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -526 2,000 -20.82 176.51 -92,844 353,020
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -90 2,526 -3.44 174.33 -15,690 440,358
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -642 2,616 -19.71 173.06 -111,105 452,725
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,434 3,258 -30.56 172.10 -246,791 560,702
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -1,235 4,692 -20.84 171.16 -211,383 803,083
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,872 5,927 -45.12 169.71 -826,827 1,005,871
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -4,948 10,799 -31.42 168.95 -835,965 1,824,491
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -253 15,747 -1.58 166.04 -42,008 2,614,632
2022-04-05 2022-04-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15,000 16,000 1,500.00 11.33 169,950 181,280
2022-02-17 2022-02-16 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 146,900 146,900
2022-01-05 2022-01-04 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 1,638 1,638
2021-11-12 2021-11-09 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 1 1 43.36 43 43
2021-08-18 2021-08-18 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1,181 108,849 1.10 106.10 125,304 11,548,879
2021-08-18 2021-08-17 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 1,183 107,668 1.11 105.63 124,960 11,372,971
2021-07-19 2021-07-15 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,032 4,032
2021-06-11 2021-06-10 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2021-06-04 2021-06-03 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2021-02-24 2021-02-23 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
A - Award 161,850 161,850
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292,207 292,207
2021-01-15 2020-03-31 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292,207 0 -100.00
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift 292,207 292,207
2021-01-15 2020-03-30 5 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
G - Gift -292,207 0 -100.00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
M - Exercise X -15,000 0 -100.00
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -15,000 1,000 -93.75 140.00 -2,100,000 140,000
2020-12-22 2020-12-18 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 15,000 16,000 1,500.00 9.30 139,500 148,800
2020-07-06 2020-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 4,581 4,581
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Option (right to buy)
M - Exercise -292,207 0 -100.00
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
S - Sale -292,207 106,485 -73.29 103.50 -30,243,424 11,021,198
2020-06-30 2020-06-29 4 KRTX Karuna Therapeutics, Inc.
Common Stock
M - Exercise 292,207 398,692 274.41 0.11 32,143 43,856
2020-06-11 2020-06-09 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2020-06-05 2020-06-04 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2020-02-19 2020-02-14 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -140,000 140,000 -50.00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
M - Exercise X -30,000 0 -100.00
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
S - Sale X -30,000 1,000 -96.77 130.00 -3,900,000 130,000
2020-02-11 2020-02-10 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
M - Exercise X 30,000 31,000 3,000.00 14.67 440,100 454,770
2019-07-02 2019-07-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Series A Preferred Stock
C - Conversion -74,294 0 -100.00
2019-07-02 2019-07-02 4 KRTX Karuna Therapeutics, Inc.
Common Stock
C - Conversion 96,485 106,485 964.85
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -71,121 71,121 -50.00
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 3,200 10,000 47.06 23.43 74,976 234,300
2019-07-01 2019-06-28 4 KRTX Karuna Therapeutics, Inc.
Common Stock
P - Purchase 6,800 6,800 22.86 155,448 155,448
2019-07-01 2019-06-27 4 KRTX Karuna Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award -616,703 616,703 -50.00
2019-06-17 2019-06-13 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2019-06-06 2019-06-05 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,967 122,400 -1.58 161.02 -316,726 19,708,848
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2,919 124,367 -2.29 161.05 -470,105 20,029,305
2019-03-22 2019-03-21 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -2,993 127,286 -2.30 161.04 -481,993 20,498,137
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13,047 130,279 -9.10 161.35 -2,105,133 21,020,517
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -13,096 143,326 -8.37 161.32 -2,112,647 23,121,350
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -16,182 156,422 -9.38 161.20 -2,608,538 25,215,226
2019-03-20 2019-03-20 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -14,321 172,604 -7.66 161.32 -2,310,264 27,844,477
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -875 186,925 -0.47 161.01 -140,884 30,096,794
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -800 187,800 -0.42 161.02 -128,816 30,239,556
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,200 188,600 -0.63 161.14 -193,368 30,391,004
2019-03-20 2019-03-18 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -900 189,800 -0.47 161.01 -144,909 30,559,698
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 190,700 -0.37 161.00 -112,700 30,702,700
2019-03-05 2019-03-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 192,100 -0.26 161.00 -80,500 30,928,100
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 193,300 18.81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 193,300 18.81
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 435,477 7.56
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 30,600 404,877 8.18
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -122,400 119,295 -50.64
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70,900 -0.70 161.00 -80,500 11,414,900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 70,900 -0.70 161.00 -80,500 11,414,900
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344,177 -0.15 161.00 -80,500 55,412,497
2019-02-27 2019-02-25 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 344,677 -0.14 161.00 -80,500 55,492,997
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72,900 -0.27 162.00 -32,400 11,809,800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -200 72,900 -0.27 162.00 -32,400 11,809,800
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -643 73,100 -0.87 161.37 -103,761 11,796,147
2019-02-20 2019-02-19 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -500 73,743 -0.67 161.62 -80,812 11,918,639
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,388 74,443 -14.27 161.02 -1,994,716 11,986,812
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,044 86,831 -12.18 161.02 -1,939,325 13,981,528
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,510 98,875 -11.23 161.02 -2,014,360 15,920,852
2019-02-20 2019-02-15 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -12,519 111,385 -10.10 161.02 -2,015,809 17,935,213
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 241,695 241,695
2019-02-20 2019-02-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -241,695 272,777 -46.98
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 123,904 123,904
2019-02-14 2018-07-26 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -123,904 0 -100.00
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift 121,035 123,904 4,218.72
2019-02-14 2018-07-13 5 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -121,035 514,472 -19.05
2018-06-22 2018-06-20 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 9,000 9,000
2018-06-08 2018-06-06 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 10,000 10,000
2018-03-09 2018-03-07 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 110,000 110,000
2018-03-08 2018-03-06 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -58,139 632,712 -8.42 172.00 -9,999,908 108,826,464
2017-06-08 2017-06-07 4 SAGE Sage Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 14,000 14,000
2017-06-06 2017-06-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2017-02-17 2017-01-31 4 SAGE Sage Therapeutics, Inc.
Common Stock
J - Other 2,174 690,851 0.32 3.15 6,848 2,176,181
2017-02-10 2017-02-08 4 VYGR Voyager Therapeutics, Inc.
Stock Option (Right to Buy)
A - Award 240,000 240,000 11.83 2,839,200 2,839,200
2016-06-24 2016-06-22 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13,922 13,922 28.35 394,689 394,689
2016-06-07 2016-06-03 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 4,763,954 -0.02
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 4,763,954 -0.01
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -423 678,569 -0.06
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678,992 -0.12
2016-04-05 2016-02-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
G - Gift -847 678,992 -0.12
2016-02-02 2016-02-01 4 VYGR Voyager Therapeutics, Inc.
Stock Options (Right to Buy)
A - Award 200,000 200,000 11.09 2,218,000 2,218,000
2016-01-15 2016-01-14 4 VYGR Voyager Therapeutics, Inc.
Common Stock
P - Purchase 10,000 872,351 1.16 14.07 140,690 12,273,106
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -624 0 -100.00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
D - Sale to Issuer -374 0 -100.00
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -4,430 0 -100.00 92.78 -411,015
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -6,800 0 -100.00 74.77 -508,436
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10,000 0 -100.00 71.10 -711,000
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
D - Sale to Issuer -10,000 0 -100.00 69.14 -691,400
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 57.76 -577,600
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 44.58 -445,800
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -10,000 0 -100.00 57.05 -570,500
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
D - Sale to Issuer -20,000 0 -100.00 38.71 -774,200
2015-11-19 2015-11-18 4 SIAL SIGMA ALDRICH CORP
Common Stock
D - Sale to Issuer -478 0 -100.00 140.00 -66,920
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1,724,702
2015-11-10 3 VYGR Voyager Therapeutics, Inc.
Common Stock
1,724,702
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,518 683,650 -1.37 52.10 -495,888 35,618,165
2015-09-02 2015-09-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -10,482 693,168 -1.49 52.69 -552,297 36,523,022
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -6,020 703,650 -0.85 66.42 -399,848 46,736,433
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,158 709,670 -1.27 67.05 -614,044 47,583,374
2015-08-04 2015-08-03 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4,822 718,828 -0.67 67.98 -327,800 48,865,927
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -803 723,650 -0.11 67.46 -54,170 48,817,429
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -9,702 724,453 -1.32 68.12 -660,900 49,349,738
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,859 734,155 -0.25 68.90 -128,085 50,583,280
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -1,600 736,014 -0.22 70.50 -112,800 51,888,987
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -5,336 737,614 -0.72 71.47 -381,364 52,717,273
2015-07-02 2015-07-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -700 742,950 -0.09 72.44 -50,708 53,819,298
2015-06-15 2015-05-29 4 SIAL SIGMA ALDRICH CORP
Common Stock
G - Gift -7,779 478 -94.21
2015-06-03 2015-06-01 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 11,250 11,250
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -8,705 743,650 -1.16 71.36 -621,153 53,063,815
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3,291 752,355 -0.44 72.06 -237,162 54,217,560
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -4,604 755,646 -0.61 73.13 -336,710 55,263,641
2015-06-02 2015-06-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale X -3,400 760,250 -0.45 74.05 -251,774 56,297,425
2015-05-29 2015-05-28 4 SAGE Sage Therapeutics, Inc.
Stock Options (Right to buy)
A - Award 13,922 13,922 73.13 1,018,116 1,018,116
2015-05-05 2015-05-01 4 BFAM Sage Therapeutics, Inc.
Common Stock
S - Sale X -20,000 763,650 -2.55 53.31 -1,066,200 40,710,182
2015-04-02 2015-04-01 4 SAGE Sage Therapeutics, Inc.
Common Stock
S - Sale -20,000 783,650 -2.49 48.51 -970,200 38,014,862
2015-01-28 2015-01-26 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Common Stock
P - Purchase 1,000 1,000 95.00 95,000 95,000
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -311 624 -33.26
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 374 -49.93
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 311 8,257 3.91
2015-01-09 2015-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7,946 4.93
2014-07-23 2014-07-23 4 SAGE Sage Therapeutics, Inc.
Common Stock
P - Purchase 10,000 803,650 1.26 18.00 180,000 14,465,700
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1,587,300
2014-07-17 3 SAGE Sage Therapeutics, Inc.
Common Stock
1,587,300
2014-06-06 2014-06-05 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15,000 15,000
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
M - Exercise -373 747 -33.30
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 935 935
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 4,430 4,430
2014-01-06 2014-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock
M - Exercise 373 7,573 5.18
2014-01-03 2014-01-02 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 3,388 3,388
2013-06-10 2013-06-06 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
Restricted Stock Unit
A - Award 1,120 1,120
2013-01-04 2013-01-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option Right to Buy
A - Award 6,800 6,800
2012-06-25 2012-06-21 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
A - Award 15,000 15,000
2012-05-04 2012-05-02 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000
2012-01-19 2012-01-03 4/A SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1,200 7,200 20.00
2012-01-05 2012-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock
A - Award 1,200 2,400 100.00
2011-06-13 2011-06-09 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Stock Option (right to buy)
A - Award 15,000 15,000
2011-05-06 2011-05-04 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000 69.14 691,400 691,400
2011-01-05 2011-01-03 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 6,000 25.00 67.30 80,760 403,800
2010-09-24 2010-09-22 4 ALNY ALNYLAM PHARMACEUTICALS, INC.
Non-Qualified Stock Option (right to buy)
A - Award 30,000 30,000
2010-01-11 2010-01-07 4 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 4,800 33.33 50.59 60,708 242,832
2009-05-07 2009-05-06 4 SIAL SIGMA ALDRICH CORP
NQ Stock Option, Right to Buy
A - Award 10,000 10,000 44.58 445,780 445,780
2009-01-06 2009-01-02 4 SIAL SIGMA ALDRICH CORP
Common Stock, Par Value $1
A - Award 1,200 1,200
2009-01-06 2009-01-02 4/A SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
A - Award 1,200 3,600 50.00
2006-11-15 3 SIAL SIGMA ALDRICH CORP
Common Stock, $1 Par Value
0
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)